The RAGE Inhibitor TTP488 (Azeliragon) Demonstrates Anti-Tumor Activity and Enhances the Efficacy of Radiation Therapy in Pancreatic Cancer Cell Lines
Kumari Alka(Wayne State University), Prakash Chinnaiyan(Oakland University)
Cited by 6
Related Papers
Enhanced fatty acid oxidation provides glioblastoma cells metabolic plasticity to accommodate to its dynamic nutrient microenvironment
|Cell Death and Disease|2020|143
Enhancing the antitumor activity of ErbB blockade with histone deacetylase (HDAC) inhibition
|International Journal of Cancer|2005|44
Impaired mitochondrial dynamics and removal of the damaged mitochondria in diabetic retinopathy
|Frontiers in Endocrinology|2023|36